Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $556634.0.

  • BioRestorative Therapies' Goodwill & Intangibles fell 1388.45% to $556634.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $556634.0, marking a year-over-year decrease of 1388.45%. This contributed to the annual value of $623945.0 for FY2024, which is 1257.5% down from last year.
  • According to the latest figures from Q3 2025, BioRestorative Therapies' Goodwill & Intangibles is $556634.0, which was down 1388.45% from $579071.0 recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Goodwill & Intangibles registered a high of $803438.0 during Q4 2022, and its lowest value of $530298.0 during Q3 2022.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $636320.0 (2021), whereas its average is $650677.2.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first surged by 3881.4% in 2023, then crashed by 1388.45% in 2025.
  • BioRestorative Therapies' Goodwill & Intangibles (Quarter) stood at $589740.0 in 2021, then soared by 36.24% to $803438.0 in 2022, then fell by 11.17% to $713692.0 in 2023, then dropped by 12.58% to $623945.0 in 2024, then fell by 10.79% to $556634.0 in 2025.
  • Its last three reported values are $556634.0 in Q3 2025, $579071.0 for Q2 2025, and $601508.0 during Q1 2025.